Drugs & Targets Accelerated Approval Granted To Keytruda in Metastatic Melanoma September 05, 2014Vol.40 No.33
Drugs & Targets European Medicines Agency acclerates assessment of lenvatinib September 05, 2014Vol.40 No.33
Drugs & Targets FDA approves new use for Avastin in late-stage cervical cancer September 05, 2014Vol.40 No.33
Drugs & Targets FDA approves Cologuard; CMS issues national coverage determination September 05, 2014Vol.40 No.33
Drugs & Targets Breakthrough Therapy designation granted to blinatumomab in Ph- ALL July 11, 2014Vol.40 No.28
Drugs & Targets European Commission approves Halaven for metastatic breast cancer July 11, 2014Vol.40 No.28
Drugs & Targets Mylan launches generic Carboplatin Injection in multi-dose vials July 11, 2014Vol.40 No.28
